(Q50050305)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

title

The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

author name string

Zhen Huang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Zhijie Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Hua Bai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Meina Wu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Tongtong An

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Jun Zhao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Lu Yang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Jianchun Duan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Yuyan Wang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Shuhang Wang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Jie Wang

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

publication date

1 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

page(s)

334-340

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

30 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

Comparison of clinical outcome of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

Epidermal growth factor receptor activation: how exon 19 and 21 mutations changed our understanding of the pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00133.X

10.1111/J.1759-7714.2012.00133.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28920271%20AND%20SRC:MED&resulttype=core&format=json

release_bvph5q7ukvabdpm2gzjrp7gfri

30 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bvph5q7ukvabdpm2gzjrp7gfri

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference